Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Acta Diabetologica|February 9, 2026
Effect of metformin dose reduction versus continuation at imeglimin initiation on glycemic control in type 2 diabetes: a retrospective real-world analysisYoshiro Fushimi, Tomohiko Kimura, Junpei Sanada, et al.
Diabetes, Obesity & Metabolism|July 23, 2024
Effectiveness of switching from dipeptidyl peptidase-4 inhibitor to oral glucagon-like peptide-1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matchingHideyuki Iwamoto, Tomohiko Kimura, Yoshiro Fushimi, et al.
Internal Medicine (Tokyo, Japan)|April 8, 2026
A Case of Autoimmune Polyendocrine Syndrome Type 3C with Warm-type Autoimmune Hemolytic Anemia which Developed during Treatment for Hashimoto's ThyroiditisYuichiro Iwamoto, Masahiro Komi, Yoshiro Fushimi, et al.
Frontiers in Endocrinology|August 16, 2023
Immune checkpoint inhibitor-induced hypothyroidism predicts treatment response in Japanese subjectsYuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, et al.
Diabetes, Obesity & Metabolism|March 20, 2024
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed miceYuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, et al.
Endocrine Journal|July 2, 2025
Development of a prediction model by combining tumor diameter and clinical parameters of adrenal incidentalomaYuichiro Iwamoto, Tomohiko Kimura, Yuichi Morimoto, et al.
Endocrine Journal|May 10, 2026
Overlap syndrome between sarcoidosis and Sjögren's disease presenting as hypopituitarism: case report and review of literatureYuichiro Iwamoto, Noriko Yoshimura, Ayaka Harada, et al.
Scientific Reports|August 17, 2023
Simple standing test without furosemide is useful in the diagnosis of primary aldosteronismYuichiro Iwamoto, Tomohiko Kimura, Mana Ohnishi, et al.
Diabetes, Obesity & Metabolism|September 30, 2024
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β-cells and hepatic steatosis in obese type 2 diabetic db/db miceYuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, et al.
Scientific Reports|March 29, 2025
Blocking mineralocorticoid signaling with esaxerenone reduces atherosclerosis in hyperglycemic ApoE KO mice without affecting blood pressure and glycolipid metabolismHideyuki Iwamoto, Junpei Sanada, Tomohiko Kimura, et al.
Pageof 8